Contact Support
Narrow By
BD Institute for Medication Management Excellence blog
Maintaining Vigilance for Diversion during the COVID-19 Pandemic
ms Sep 18, 2020
In the midst of the COVID crisis, it is easy to let the urgent take our eyes off matters that will eventually demand our attention. One of those matters is the ongoing risk of drug diversion. If anything, the current COVID pandemic may increase opportunities for diversion within health systems.
Combating infectious disease: A summary of updates from the Centers for Medicare & Medicaid Services (CMS)
ms Feb 10, 2020
Drug-resistant infections take an enormous toll on patients and hospitals. BD thought leaders consider the impact of new government regulations on the fight against antimicrobial resistance.
Filtering out the Facts: Key insights from a recent white paper on the performance of in-line filters for Parenteral Nutrition and Intravenous Fat Emulsion Infusions
Jan 13, 2020
In-line filters are required for administration of intravenous fat emulsions (IVFE) and parenteral nutrition (PN) to prevent large particulates and precipitates from entering the patients’ blood stream. However, use of in-line filters can present clinical challenges. Marianne Gill shares highlights from her recent white paper on optimizing in-line filter performance.
To centralize pharmacy services and gain efficiencies, healthcare systems must first solve the 340B barrier
mm Dec 17, 2019
Despite the trend toward centralization of many hospital services, healthcare systems have been slow to do the same with pharmacy.
How big is the drug diversion problem? Nobody knows!
di Dec 2, 2019
Drug diversion in hospitals is taking a toll on personal and professional lives, but unlike the national opioid crisis, data is hard to come by. Pharmacy thought leader Dennis Tribble looks into the void.
An update on drug resistance: CDC Antibiotic Threat Report 2019
ms Nov 20, 2019
Bolstered by collaboration with the healthcare industry, the Centers for Disease Control (CDC) confirms drug resistance is a considerable threat to public health in 2019. Kalvin Yu takes a closer look at how insights from the report can help clinicians confront the risks of antimicrobial resistance (AMR).
AJHP reports on pharmacy compounding workflow technology at UNC Medical Center
ms Oct 21, 2019
The results of two separate studies on gravimetric preparation of hazardous and nonhazardous compounded sterile preparations (CSPs) point to more accurate products and the potential to capture significantly more errors than volumetric preparation.
Finding and Addressing the Gaps in the IV Medication Management Process with ISMP’s Director of Consulting Services, Michelle Mandrack, MSN, RN
ms Sep 30, 2019
Learn some of the top insights shared by ISMP’s Director of Consulting Services in a recent CE course sponsored by BD. Michelle Mandrack, MSN, RN identifies common unsafe practices and at-risk behaviors associated with the preparation and administration of sterile medications that contribute to patient harm.
Transforming Antimicrobial Stewardship: The role of emerging technology
ms Sep 9, 2019
Pathogenic microorganisms can adapt to the treatments used against them, rendering many antimicrobial medications ineffective. Learn how antimicrobial stewardship programs have the potential to impact infectious disease outcomes when supported by new technologies.
How Creative Problem-Solving Tactics Become Nursing Innovations
Kelly Robke discusses highlights of a recent HIMSS panel on nursing practice, in which nurse leaders shared ideas to cultivate and support nursing innovation.